(PNOC-005) A Phase 1 Study of Modified Measles Virus (MV-NIS) for the Treatment of Children and Young Adults with Recurrent Medulloblastoma or Recurrent Atypical Teratoid Rhabdoid Tumors (ATRT)

Purpose

This study will look to determine the safety and recommended phase 2 dose of the modified measles virus (MV-NIS) in children and young adults with recurrent medulloblastoma or atypical teratoid rhabdoid tumor (ATRT).

Eligibility

  • 12 months - 39 years old 
  • Disease: Medulloblastoma

For additional information about eligibility criteria, please contact the study coordinator Jennifer King:

Procedures

  • Drug: Modified Measles Virus

For additional information about study procedures, please contact the study coordinator Jennifer King:

Age

N/A

Gender

Male
Female

Can be done from home

No

Keywords

atypical teratoid rhabdoid tumor (ATRT), recurrent medulloblastoma, pediatric brain tumor, Brain Tumors, Brain Tumor

Principal Investigator

Sridharan Gururangan, FRCP

Contact Information

jennifer.king@neurosurgery.ufl.edu

352.294.8374


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams